Michael Metcalfe
Papers
3
Total Citations
67
H-Index
2
About
Dr. Michael Metcalfe is a urologic oncologist whose research focuses on the cost-effectiveness and surgical outcomes of robotic-assisted procedures for bladder and kidney cancers. His most influential work, a 2018 study in *Urology*, demonstrated that robot-assisted radical cystectomy is cost-effective compared to open surgery when accounting for reduced hospital stays and complications, using a propensity-matched cohort to control for patient differences. This paper has been cited 34 times, highlighting its impact on surgical decision-making and healthcare economics. Metcalfe also investigated the incidence and predictors of intraoperative conversion from partial to radical nephrectomy, a 2018 study with 31 citations that provides critical guidance for surgeons managing complex kidney tumors. By identifying factors such as tumor size and location, his work helps reduce unnecessary radical surgeries and preserve renal function. Metcalfe’s research bridges clinical practice and health policy, offering evidence that robotic surgery can be both clinically effective and economically sustainable. His contributions are essential reading for urologists, health economists, and trainees seeking to optimize surgical care in an era of rising healthcare costs.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3